Advanced Genomics Market Research Report 2022: Key Disruptive Forces to Transform Health and Wellness – GlobeNewswire

Dublin, Nov. 23, 2022 (GLOBE NEWSWIRE) — The “Advanced Genomics – Key Bothersome Forces in order to Transform Health and Wellness” report has been added to ResearchAndMarkets. com’s offering.

Advances in genomics, simply put the study of an organism’s genetic material for applications, have revolutionized approaches to healthcare and precision medicine to give rise to innovations such as personalized medicine, drug discovery, plus diagnosing hereditary diseases, among others.

Using the particular publisher’s Technology Foresights model, this FutureTech Series statement categorizes 30+ disruptive forces in genomics as emerging, accelerating, and maturing innovation areas based on their rate of growth in innovation.

It also casts light on key market activities in growing innovation areas, such as Chimeric antigen receptor (CAR-T) cell therapy, nanopore sequencing, comparative genomic hybridization (CGH), and genetic data encryption on the patent grants, major geographies, major players, plus recent developments.

The awareness, knowledge, and expertise in these development areas can help transform business models, decision-making, and strategic thinking that directly influence research and development, collaboration, acquisition, plus investment decisions.

Genomics main drivers, impact, top sectors impacted by genomics, select advancement areas within genomics and their leading patent filers, and the disruptive potential associated with eight creativity areas because highlighted by patent trends, innovation drivers, recent advancements, partnerships, plus forecast with regard to genomics.

Scope

  • Key disruptive causes in genomics – presents the major motorists, impact, top sectors impacted by genomics, and rising, accelerating, and maturing invention areas with disruptive potential in genomics.
  • Emerging technology areas — overview of select emerging innovation places to capture their bothersome potential, innovation drivers, recent developments, patents trends, partnerships, and disruptive startups.
  • Outlook – Genomics technology development intensity (TII) forecast till 2025 vs an average of 35 trending technologies.

Key Topics Covered:

1. Disruptive forces in genomics

  • Major drivers and effect
  • Genomics theme exposure simply by sectors
  • Emerging, accelerating, plus maturing advancement areas
  • Definitions and styles of select innovation locations

2 . Growing innovation areas

  • Nanopore sequencing
  • Single-molecule real-time (SMRT) sequencing
  • Non-coding DNA/RNA therapy
  • Comparative genomic hybridization (CGH)
  • Nanoball sequencing
  • Single molecule sequencing
  • Chimeric antigen receptor (CAR-T) cell treatment
  • Genetic data encryption

3. Outlook

  • Genomics technology creativity intensity (TII) forecast versus the average associated with 35 trending technologies

Companies Mentioned

  • 10X Genomics
  • Access
  • Adaptive Biotechnologies
  • Agilent Technologies
  • Annogen
  • Ascus Bioscience
  • Bayer
  • BGI Group
  • BioNTech
  • bluebird bio
  • Bluestar Genomics
  • BostonGene
  • Caribou Biosciences
  • CD Genomics
  • CHUV
  • Codexis
  • Congenica
  • Corteva
  • CRISPR Therapeutics
  • Dovetail Genomics
  • Editas Medicine
  • EXUMA Biotech
  • GeneCrypt
  • Genemind
  • Genetica
  • Genomics England
  • GenomSys
  • Google
  • Gritstone Bio
  • Guardant Health
  • Hamad Bin Khalifa University
  • HAYA Therapeutics
  • Helix OpCo
  • Human Longevity
  • IBM
  • Ideaya Biosciences
  • iLAC
  • Illumina
  • Immatics
  • Inbiomotion
  • Intellia Therapeutics
  • Johnson & Johnson
  • JumpCode Genomics
  • KeyGene
  • LabCorp
  • Legend Biotech
  • Macrogen
  • Mayo Clinic
  • MS Systems
  • NantWorks
  • Natera
  • Novartis
  • Oncorus
  • Otsuka
  • Oxford Nanopore Technology
  • PacBio
  • PathogenDx
  • Personalis
  • Philips
  • Precision Biosciences
  • ProKidney
  • Quantum-Si
  • Ravel
  • Recombinetics
  • Regeneron Pharmaceuticals
  • Robotic Biology Institute
  • Roche
  • Roswell Biotechnologies
  • Roswell Biotechnologies
  • Sangamo Therapeutics
  • Seqll
  • Seven Bridges Genomics
  • SNIPR Biome
  • SOHO Global Health
  • Sophia Genetics
  • Stoke Therapeutics
  • The Bristol-Myers Squibb
  • Thermo Fisher Scientific
  • TwinStrand Biosciences
  • Unitec
  • XenoTherapeutics

For more information about this record visit https://www.researchandmarkets.com/r/dcdxse

   

Leave a Reply

Your email address will not be published. Required fields are marked *